Four Thought Financial, LLC Rocket Pharmaceuticals, Inc. Transaction History

Four Thought Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.96 - $16.64 $5,532 - $11,564	-695 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$27.42 - $48.97 $356 - $636	13 Added 1.91%	695 $20,000
Q1 2021 Nov 12, 2021	BUY	$43.34 - $65.91 $11,398 - $17,334	263 Added 62.77%	682 $30,000
Q4 2020 Nov 12, 2021	BUY	$23.3 - $59.57 $9,762 - $24,959	419 New	419 $22,000

205

92.9M

341K

107K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.63B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial, LLC with notifications on news.